Brief: Kaleido Biosciences Reports Second Quarter 2020 Financial Results And Provides Corporate Update

Kaleido Biosciences

04/08/2020 14:46

Kaleido Biosciences Inc  KLDO.O :
    * KALEIDO BIOSCIENCES REPORTS SECOND QUARTER 2020 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * Q2 LOSS PER SHARE $0.59
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.59 -- REFINITIV IBES
DATA
    * PLAN TO INITIATE NEW CLINICAL STUDY IN ULCERATIVE COLITIS
IN Q3
2020
    * COVID-19 CLINICAL DEVELOPMENT PROGRAM TOPLINE DATA READOUT
OF
MULTI-CENTER STUDY EXPECTED IN Q4

Source text for Eikon:  ID:nGNX3WJ6P3 
Further company coverage:  KLDO.O